A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2009
11/26/2009	WO2007084221A9 Methods and apparatus for identifying subject matter in view data
11/26/2009	US20090292000 Pyrrolidine derivatives as prostaglandin modulators
11/26/2009	US20090291981 5-Lipoxygenase-Activating Protein Inhibitor
11/26/2009	US20090291924 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
11/26/2009	US20090291143 Combination of Azelastine and Steroids
11/26/2009	US20090291050 Particulate materials
11/26/2009	CA2761971A1 Rice bran extracts for inflammation and methods of use thereof
11/26/2009	CA2724592A1 Agent for maintenance of induced remission
11/26/2009	CA2724584A1 Phenyl or pyridinyl substituted indazoles derivatives
11/26/2009	CA2724508A1 Phenyl and benzodioxinyl substituted indazoles derivatives
11/26/2009	CA2724357A1 Novel thiophenediamine derivative having urea structure
11/25/2009	EP2123752A2 Novel nucleic acid
11/25/2009	EP2123747A1 Mesenchymal stem cells for use in treating a pulmonary disease or in reducing scar tissue
11/25/2009	EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
11/25/2009	EP2123650A1 Novel form of tiotropium bromide and process for preparation thereof
11/25/2009	EP2123299A1 Therapeutic agent for interstitial pulmonary disease comprising anti-hmgb-1 antibody
11/25/2009	EP2123295A1 Therapeutic agent for interstitial pneumonia
11/25/2009	EP2121686A1 Indolizineacetic acids and their therapeutic use as ligands of the crth2 receptor
11/25/2009	EP2121594A1 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists
11/25/2009	EP2120961A1 Treprostinil treatment for interstitial lung disease and asthma
11/25/2009	EP2120936A1 Novel methods
11/25/2009	EP2120935A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
11/25/2009	EP1856050B1 Crystalline forms of a biphenyl compound
11/25/2009	EP1828172B1 Pyrrole derivatives having crth2 receptor antagonist activity
11/25/2009	EP1691783B1 Pre-metered dry powder inhaler for moisture-sensitive medicaments
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	CN201350225Y Cough and asthma relief black patch
11/25/2009	CN101589047A Cathepsin proteases inhibitors
11/25/2009	CN101586143A Modulating production of pneumococcal capsular polysaccharide
11/25/2009	CN101585835A Preparation method and application of bencycloquidium bromide optical isomer and composition of bencycloquidium bromide optical isomer
11/25/2009	CN101584852A Pharmaceutical preparation for getting rid of phlegm and retained fluid
11/25/2009	CN101584830A Traditional Chinese medicine for treating chronic hyperplastic laryngitis
11/25/2009	CN101584828A Preparation for Chinese medicinal composition for clearing lung-heat
11/25/2009	CN101584827A Traditional Chinese medicine for treating cold in children
11/25/2009	CN101584821A Compound polygala mixture used for relieving cough and expelling phlegm and preparation method thereof
11/25/2009	CN101584793A Pure natural health-care four-Huai medicine
11/25/2009	CN101584785A Chinese medicament for treating acute nasopharyngitis
11/25/2009	CN101584752A Extraction and purification process for total flavonoids in Anchusa italica Retiz
11/25/2009	CN101584735A Pharmaceutical composition for preventing and treating chicken bursal disease and nephrotic bronchitis and preparation method thereof
11/25/2009	CN101584654A Ofloxacin nasal drops as well as preparation method and quality control method thereof
11/25/2009	CN101584466A Natural lung-nourishing asthma-relieving egg and preparation method thereof
11/25/2009	CN101584458A Health-protection tea for relieving inflammation and resolving phlegm for middle-aged people
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562328C Chinese medicinal composition for treating cold
11/24/2009	US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009	US7622484 Such as asthma or chronic obstructive pulmonary disease; a corticoid such as mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or salt such as maleate
11/24/2009	US7622483 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis
11/24/2009	US7622480 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
11/24/2009	US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009	US7622450 Flavone C-glycoside derivatives and compositions containing the derivatives
11/24/2009	US7622297 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2434381C Naphthostyrils
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2382651C Use of simple amino acids to form porous particles
11/19/2009	WO2009140642A2 Tricyclic antagonists of prostaglandin d2 receptors
11/19/2009	WO2009140204A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	WO2009139710A1 Quinuclidine derivatives and their use as muscarinic receptor antagonists
11/19/2009	WO2009139709A1 Quinuclidine derivatives and their use as muscarinic receptor antagonists for the treatment of asthma and chronic obstructive pulmonary disease (copd)
11/19/2009	WO2009139708A1 PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A β2-ADRENOCEPTOR AGONIST
11/19/2009	WO2009139707A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009138762A2 Therapeutic use of peptides
11/19/2009	WO2009138758A2 Bis-aryl compounds for use as medicaments
11/19/2009	WO2009138707A1 Quinuclidine derivatives as muscarinic m3 receptor antagonists
11/19/2009	WO2009138413A1 Single domain antibodies that bind il-13
11/19/2009	WO2009138378A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases
11/19/2009	WO2009116524A9 Modified protein
11/19/2009	WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286854 Aptamers directed to muci
11/19/2009	US20090286835 Novel compounds
11/19/2009	US20090286813 Thioxanthine Derivatives and Their Use as Inhibitors of MPO
11/19/2009	US20090286793 Pde4b inhibitors and uses therefor
11/19/2009	US20090286744 Treatment of asthma
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286734 Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
11/19/2009	US20090286312 Methods and Compositions for Treating Allergic Diseases
11/19/2009	US20090285917 Composition comprising complex crude drug extracts showing anti-allergic rhinitis, anti-atopic dermatitis and anti-asthma activity
11/19/2009	US20090285900 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285899 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285898 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	US20090285811 Anti-inflammatory and immunosuppressive glucocorticoid steroids
11/19/2009	DE112007003136T5 Ein Extrakt An extract
11/19/2009	CA2724435A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	CA2724277A1 Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
11/19/2009	CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009	CA2723981A1 New compounds 273
11/19/2009	CA2723938A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
11/19/2009	CA2723909A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta2-adrenoceptor agonist
11/18/2009	EP2119718A1 Macrocyclic compound
11/18/2009	EP2119716A1 Aza-bridged-ring compound
11/18/2009	EP2119446A1 Epithelium improving agent
11/18/2009	EP2118142A2 Humaneered anti-factor b antibody
11/18/2009	EP2118093A1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
11/18/2009	EP2118084A1 Salts 668
11/18/2009	EP2118078A2 New salt

1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 878